Related News

Home » World

New drugs needed to tackle superbugs

EUROPEAN health agencies warn there are not enough new drugs under development to tackle the growing problem of superbugs in Europe.

In a joint report, the European Centre for Disease Control and the European Medicines Agency urge policy-makers to set up global and European strategies to address the problem of multidrug-resistant bacteria.

They say around 25,000 patients die in the European Union each year from antibiotic-resistant bacteria, which costs society 1.5 billion euro (US$2.2 billion) a year.

Today's report said only 15 new anti-bacterial drugs are under development, most of which are in very early stages.

MRSA, or methicillin-resistant Staphylococcus aureus, is the most common superbug, but others are increasing steadily.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend